BAMS
Bellevue Asset Management (Switzerland) Portfolio holdings
AUM
$656M
This Quarter Return
-14.54%
1 Year Return
+11.48%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$613M
AUM Growth
+$613M
(-15%)
Cap. Flow
+$8.51M
Cap. Flow
% of AUM
1.39%
Top 10 Holdings %
Top 10 Hldgs %
30.19%
Holding
150
New
11
Increased
47
Reduced
31
Closed
17
Top Buys
| 1 |
Supernus Pharmaceuticals
SUPN
|
$4.49M |
| 2 |
Amgen
AMGN
|
$3.2M |
| 3 |
Larimar Therapeutics
LRMR
|
$3.2M |
| 4 |
INSY
Insys Therapeutics, Inc.
INSY
|
$2.56M |
| 5 |
Incyte
INCY
|
$2.21M |
Top Sells
| 1 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$6.46M |
| 2 |
Cardinal Health
CAH
|
$3.3M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
$3.09M |
| 4 |
Alkermes
ALKS
|
$2.96M |
| 5 |
THOR
THORATEC CORPORATION
THOR
|
$2.45M |
Sector Composition
| 1 | Healthcare | 91.86% |
| 2 | Financials | 0.95% |
| 3 | Industrials | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $24.9M | 4.07% | 254,050 +19,150 | +8% | +$1.88M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $24.9M | 4.05% | 229,760 +1,080 | +0.5% | +$117K |
|
3
Biogen
BIIB
$19.4B
| $20.9M | 3.42% | 71,770 -990 | -1% | -$289K |
|
4
Abbott
ABT
$231B
| $18.6M | 3.04% | 463,000 | – | – |
|
5
Regeneron Pharmaceuticals
REGN
$61.5B
| $18.1M | 2.95% | 38,900 +100 | +0.3% | +$46.5K |
|
6
Medtronic
MDT
$119B
| $18.1M | 2.95% | 270,000 -10,000 | -4% | -$669K |
|
|
7
Amgen
AMGN
$155B
| $16.6M | 2.71% | 120,000 +23,134 | +24% | +$3.2M |
|
8
Illumina
ILMN
$15.8B
| $15.4M | 2.51% | 87,625 +4,886 | +6% | +$859K |
|
9
UnitedHealth
UNH
$281B
| $13.9M | 2.27% | 120,000 +5,000 | +4% | +$580K |
|
|
AGN
10
DELISTED
Allergan plc
AGN
| $13.6M | 2.22% | 50,150 +730 | +1% | +$198K |
|
11
Stryker
SYK
$150B
| $13.2M | 2.16% | 140,700 | – | – |
|
|
ESRX
12
DELISTED
Express Scripts Holding Company
ESRX
| $13M | 2.11% | 160,000 | – | – |
|
13
Becton Dickinson
BDX
$55.3B
| $12.2M | 2% | 92,305 +1,675 | +2% | +$222K |
|
|
ENDP
14
DELISTED
Endo International plc
ENDP
| $10.9M | 1.79% | 158,000 -30,000 | -16% | -$2.08M |
|
15
Teva Pharmaceuticals
TEVA
$21.1B
| $9.55M | 1.56% | 169,220 +2,270 | +1% | +$128K |
|
16
Viatris
VTRS
$12.3B
| $9.06M | 1.48% | 225,000 | – | – |
|
17
Zimmer Biomet
ZBH
$21B
| $8.97M | 1.46% | 95,500 | – | – |
|
18
Vertex Pharmaceuticals
VRTX
$100B
| $8.59M | 1.4% | 82,500 -6,000 | -7% | -$625K |
|
|
19
Incyte
INCY
$16.5B
| $8.5M | 1.39% | 77,000 +20,000 | +35% | +$2.21M |
|
20
Dr. Reddy's Laboratories
RDY
$11.8B
| $8.31M | 1.36% | 130,000 | – | – |
|
21
Ligand Pharmaceuticals
LGND
$3.15B
| $8.2M | 1.34% | 95,730 +19,540 | +26% | +$1.67M |
|
22
Cigna
CI
$80.3B
| $7.83M | 1.28% | 58,000 +13,000 | +29% | +$1.76M |
|
|
ALXN
23
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $7.73M | 1.26% | 49,400 -2,346 | -5% | -$367K |
|
|
CYTO
24
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $7.72M | 1.26% | 2,169,625 | – | – |
|
|
STJ
25
DELISTED
St Jude Medical
STJ
| $7.7M | 1.26% | 122,000 -28,000 | -19% | -$1.77M |
|